Deiodinases: Implications of the local control of thyroid hormone action

Journal of Clinical Investigation

Volumn 116, Issue 10, 2006, Pages 2571-2579

  Bianco, Antonio C ^a   Kim, Brian W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEIODINASE TYPE 2 ENZYME; IODIDE PEROXIDASE; IODOTHYRONINE SELENODEIODINASE ENZYME; THYROID HORMONE; UNCLASSIFIED DRUG;

DEIODINATION; DEVELOPMENTAL STAGE; ENERGY EXPENDITURE; HOMEOSTASIS; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THYROID GLAND; WILD TYPE;

ANIMALS; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; IODIDE PEROXIDASE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; THYROID HORMONES;

EID: 33749431724     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI29812     Document Type: Review

References (99)

1. Wu, Y., and Koenig, R.J. 2000. Gene regulation by thyroid hormone. Trends Endocrinol. Metab. 11:207-211.
2. Wondisford, F.E. 2003. Thyroid hormone action: insight from transgenic mouse models. J. Investig. Med. 51:215-220.
3. Yen, P.M., et al. 2006. Thyroid hormone action at the cellular, genomic and target gene levels. Mol. Cell. Endocrinol. 246:121-127.
4. St. Germain, D.L., and Galton, V.A. 1997. The deiodinase family of selenoproteins. Thyroid. 7:655-668.
5. Bianco, A.C., Salvatore, D., Gereben, B., Berry, M.J., and Larsen, P.R. 2002. Biochemistry, cellular and molecular biology and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23:38-89.
6. Kohrle, J., Jakob, F., Contempre, B., and Dumont, J.E. 2005. Selenium, the thyroid, and the endocrine system. Endocr. Rev. 26:944-984.
7. Bianco, A.C., and Larsen, P.R. 2005. Cellular and structural biology of the deiodinases. Thyroid. 15:777-786.
8. Leonard, J.L., Visser, T.J., and Leonard, D.M. 2001. Characterization of the subunit structure of the catalytically active type I iodothyronine deiodinase. J. Biol. Chem. 276:2600-2607.
9. Callebaut, I., et al. 2003. The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase-clan GH-A-like structure. J. Biol. Chem. 278:36887-36896.
10. Curcio-Morelli, C., et al. 2003. In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases. Endocrinology. 144:937-946.
11. Kuiper, G.G., Kester, M.H., Peeters, R.P., and Visser, T.J. 2005. Biochemical mechanisms of thyroid hormone deiodination. Thyroid. 15:787-798.
12. Jansen, J., Friesema, E.C., Milici, C., and Visser, T.J. 2005. Thyroid hormone transporters in health and disease. Thyroid. 15:757-768.
13. Oppenheimer, J.H. 1979. Thyroid hormone action at the cellular level. Science. 203:971-979.
14. Larsen, P.R., Silva, J.E., and Kaplan, M.M. 1981. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr. Rev. 2:87-102.
15. Bianco, A.C., and Silva, J.E. 1987. Nuclear 3,5,3′- triiiodothyronine (T3) in brown adipose tissue: receptor occupancy and sources of T3 as determined by in vivo techniques. Endocrinology. 120:55-62.
16. Peeters, R.P., Debaveye, Y., Fliers, E., and Visser, T.J. 2006. Changes within the thyroid axis during critical illness. Crit. Care Clin. 22:41-55.
17. Martino, E., Bartalena, L., Bogazzi, F., and Braverman, L.E. 2001. The effects of amiodarone on the thyroid. Endocr. Rev. 22:240-254.
18. Huang, S.A., et al. 2000. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N. Engl. J. Med. 343:185-189.
19. Huang, S.A., et al. 2002. A 21-year-old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase. J. Clin. Endocrinol. Metab. 87:4457-4461.
20. Huang, S.A., Dorfman, D.M., Genest, D.R., Salvatore, D., and Larsen, P.R. 2003. Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J. Clin. Endocrinol. Metab. 88:1384-1388.
21. Wasco, E.C., et al. 2003. Determinants of iodothyronine deiodinase activities in rodent uterus. Endocrinology. 144:4253-4261.
22. Alexander, E.K., et al. 2004. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N. Engl. J. Med. 351:241-249.
23. Peeters, R.P., et al. 2005. A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. J. Clin. Endocrinol. Metab. 90:256-263.
24. Peeters, R.P., et al. 2005. A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. Am. J. Physiol. Endocrinol. Metab. 289:E75-E81.
25. Appelhof, B.C., et al. 2005. Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3′-triiodothyronine therapy. J. Clin. Endocrinol. Metab. 90:6296-6299.
26. Peeters, R.P., et al. 2003. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J. Clin. Endocrinol. Metab. 88:2880-2888.
27. Mentuccia, D., et al. 2002. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes. 51:880-883.
28. Dentice, M., et al. 2005. The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat. Cell Biol. 7:698-705.
29. Watanabe, M., et al. 2006. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 439:484-489.
30. Schimmel, M., and Utiger, R.D. 1977. Thyroidal and peripheral production of thyroid hormones. Review of recent findings and their clinical implications. Ann. Intern. Med. 87:760-768.
31. Geffner, D.L., Azukizawa, M., and Hershman, J.M. 1975. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. J. Clin. Invest. 55:224-229.
32. Saberi, M., Sterling, F.H., and Utiger, R.D. 1975. Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. J. Clin. Invest. 55:218-223.
33. Maia, A.L., Kim, B.W., Huang, S.A., Harney, J.W., and Larsen, P.R. 2005. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J. Clin. Invest. 115:2524-2533. doi:10.1172/JCI25083.
34. Abuid, J., and Larsen, P.R. 1974. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents. J. Clin. Invest. 54:201-208.
35. Zavacki, A.M., et al. 2005. Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse. Endocrinology. 146:1568-1575.
36. Gereben, B., Goncalves, C., Harney, J.W., Larsen, P.R., and Bianco, A.C. 2000. Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. Mol. Endocrinol. 14:1697-1708.
37. Steinsapir, J., Harney, J., and Larsen, P.R. 1998. Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes. J. Clin. Invest. 102:1895-1899.
38. Curcio-Morelli, C., et al. 2003. Deubiquitination of type 2 iodothyronine deiodinase by pVHL-interacting deubiquitinating enzymes regulates thyroid hormone activation. J. Clin. Invest. 112:189-196. doi:10.1172/JCI200318348.
39. St. Germain, D.L., Hernandez, A., Schneider, M.J., and Galton, V.A. 2005. Insights into the role of deiodinases from studies of genetically modified animals. Thyroid. 15:905-916.
40. Schneider, M.J., et al. 2006. Targeted disruption of the type 1 selenodeiodinase gene (dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology. 147:580-589.
41. Schneider, M.J., et al. 2001. Targeted disruption of the type 2 selenodeiodinase gene (Dio2) results in a phenotype of pituitary resistance to T4. Mol. Endocrinol. 15:2137-2148.
42. Berry, M.J., et al. 1993. Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5′ deiodinase deficiency. J. Clin. Invest. 92:1517-1528.
43. Schoenmakers, C.H.H., Pigmans, I.G.A.J., Poland, A., and Visser, T.J. 1993. Impairement of the selenoenzyme type I iodothyronine deiodinase in C3H/He mice. Endocrinology. 132:357-361.
44. Christoffolete, M.A., et al. 2006. Mice with combined targeted disruption of the Dio2 gene and a type 1 deiodinase deficient background maintain euthyroid serum T3 levels and are susceptible to diet induced obesity. In Annual Meeting of the Endocrine Society. June 24-27. Boston, Massachusetts, USA. http://www.abstracts2view.com/endo/.
45. Silva, J.E., and Larsen, P.R. 1977. Pituitary nuclear 3,5,3′-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science. 198:617-620.
46. Christoffolete, M.A., et al. 2006. Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary TSH feedback mechanism. Endocrinology. 147:1735-1743.
47. Obregon, M.J., Escobar del Rey, F., and Morreale de Escobar, G. 2005. The effects of iodine deficiency on thyroid hormone deiodination. Thyroid. 15:917-929.
48. Dumitrescu, A.M., et al. 2005. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat. Genet. 37:1247-1252.
49. Faber, J., and Siersbaek-Nielsen, K. 1996. Serum free 3,5,3′-triiodothyronine (T3) in non-thyroidal somatic illness, as measured by ultrafiltration and immunoextraction. Clin. Chim. Acta. 256:115-123.
50. Chopra, I.J. 1998. Simultaneous measurement of free thyroxine and free 3,5,3′-triiodothyronine in undiluted serum by direct equilibrium dialysis/radioimmunoassay: evidence that free triiodothyronine and free thyroxine are normal in many patients with the low triiodothyronine syndrome. Thyroid. 8:249-257.
51. Kaplan, M.M., et al. 1982. Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am. J. Med. 72:9-16.
52. De Groot, L.J. 1999. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J. Clin. Endocrinol. Metab. 84:151-164.
53. Koenig, R.J. 2005. Regulation of type 1 iodothyronine deiodinase in health and disease. Thyroid. 15:835-840.
54. Kinlaw, W.B., Schwartz, H.L., and Oppenheimer, J.H. 1985. Decreased serum triiodothyronine in starving rats is due primarily to diminished thyroidal secretion of thyroxine. J. Clin. Invest. 75:1238-1241.
55. Peeters, R.P., et al. 2003. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J. Clin. Endocrinol. Metab. 88:3202-3211.
56. De Groot, L.J. 2006. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit. Care Clin. 22:57-86.
57. Van den Berghe, G., et al. 1998. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J. Clin. Endocrinol. Metab. 83:309-319.
58. Cavalieri, R.R. 1991. The effects of nonthyroid disease and drugs on thyroid function tests. Med. Clin. North Am. 75:27-39.
59. Legradi, G., Emerson, C.H., Ahima, R.S., Flier, J.S., and Lechan, R.M. 1997. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology. 138:2569-2576.
60. Chan, J.L., Heist, K., DePaoli, A.M., Veldhuis, J.D., and Mantzoros, C.S. 2003. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J. Clin. Invest. 111:1409-1421. doi:10.1172/JCI200317490.
61. Fekete, C., et al. 2004. Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology. 145:1649-1655.
62. Zeold, A., et al. 2006. Characterization of the NF-kappaB responsiveness of the human dio2 gene. Endocrinology. 147:4419-4429.
63. Lowell, B.B., and Spiegelman, B.M. 2000. Towards a molecular understanding of adaptive thermogenesis. Nature. 404:652-660.
64. Bianco, A.C., and Silva, J.E. 1987. Intracellular conversion of thyroxine to triiodothyronine is required for the optimal thermogenic function of brown adipose tissue. J. Clin. Invest. 79:295-300.
65. Bianco, A.C., and Silva, J.E. 1988. Cold exposure rapidly induces virtual saturation of brown adipose tissue nuclear T3 receptors. Am. J. Physiol. 255:E496-E503.
66. De Jesus, L.A., et al. 2001. The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J. Clin. Invest. 108:1379-1385. doi:10.1172/JCI200113803.
67. Christoffolete, M.A., et al. 2004. Mice with targeted disruption of the Dio2 gene have cold-induced overexpression of uncoupling protein 1 gene but fail to increase brown adipose tissue lipogenesis and adaptive thermogenesis. Diabetes. 53:577-584.
68. Liu, X., et al. 2003. Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. J. Clin. Invest. 111:399-407. doi:10.1172/JCI200315737.
69. Kalaany, N.Y., et al. 2005. LXRx regulate the balance between fat storage and oxidation. Cell Metab. 1:231-244.
70. Hull, D. 1977. Brown adipose tissue and the newborn infant's response to cold. In Scientific foundations of obstetrics and gynaecology. E.E. Philipp, J. Barnes, and M. Newton, editors. William Heinemann. London, United Kingdom. 545-550.
71. Houstek, J., et al. 1993. Type II iodothyronine 5′-deiodinase and uncoupling protein in brown adipose tissue of human newborns. J. Clin. Endocrinol. Metab. 77:382-387.
72. Heaton, J.M. 1972. The distribution of brown adipose tissue in the human. J. Anat. 112:35-39.
73. Ricquier, D., Nechad, M., and Mory, G. 1982. Ultrastructural and biochemical characterization of human brown adipose tissue in pheochromocytoma. J. Clin. Endocrinol. Metab. 54:803-807.
74. Cohade, C., Mourtzikos, K.A., and Wahl, R.L. 2003. "USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. J. Nucl. Med. 44:1267-1270.
75. Hany, T.F., et al. 2002. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur. J. Nucl. Med. Mol. Imaging. 29:1393-1398.
76. Garcia, C.A., et al. 2006. Reduction of brown fat 2-deoxy-2-[F-18]fluoro- D-glucose uptake by controlling environmental temperature prior to positron emission tomography scan. Mol. Imaging Biol. 8:24-29.
77. Silva, J.E. 2005. Thyroid hormone and the energetic cost of keeping body temperature. Biosci. Rep. 25:129-148.
78. Lebon, V., et al. 2001. Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J. Clin. Invest. 108:733-737. doi:10.1172/JCI200111775.
79. Harper, M.E., and Brand, M.D. 1993. The quantitative contributions of mitochondrial proton leak and ATP turnover reactions to the changed respiration rates of hepatocytes from rats of different thyroid status. J. Biol. Chem. 268:14850-14860.
80. Desai-Yajnik, V., Zeng, J., Omori, K., Sherman, J., and Morimoto, T. 1995. The effect of thyroid hormone treatment on the gene expression and enzyme activity of rat liver sodium-potassium dependent adenosine triphosphatase. Endocrinology. 136:629-639.
81. Folke, M., and Sestoft, L. 1977. Thyroid calorigenesis in isolated, perfused rat liver: minor role of active sodium-potassium transport. J. Physiol. 269:407-419.
82. De Meis, L. 2001. Role of the sarcoplasmic reticulum Ca2+-ATPase on heat production and thermogenesis. Biosci. Rep. 21:113-137.
83. Reis, M., Farage, M., and de Meis, L. 2002. Thermogenesis and energy expenditure: control of heat production by the Ca(2+)-ATPase of fast and slow muscle. Mol. Membr. Biol. 19:301-310.
84. Izumo, S., Nadal-Ginard, B., and Mahdavi, V. 1986. All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science. 231:597-600.
85. Simonides, W.S., Thelen, M.H., van der Linden, C.G., Muller, A., and van Hardeveld, C. 2001. Mechanism of thyroid-hormone regulated expression of the SERCA genes in skeletal muscle: implications for thermogenesis. Biosci. Rep. 21:139-154.
86. Oppenheimer, J.H., Schwartz, H.L., Lane, J.T., and Thompson, M.P. 1991. Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis. J. Clin. Invest. 87:125-132.
87. Galton, V.A. 2005. The roles of the iodothyronine deiodinases in mammalian development. Thyroid. 15:823-834.
88. Brown, D.D. 2005. The role of deiodinases in amphibian metamorphosis. Thyroid. 15:815-821.
89. Marsh-Armstrong, N., Huang, H., Remo, B.F., Liu, T.T., and Brown, D.D. 1999. Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase. Neuron. 24:871-878.
90. Hernandez, A., Martinez, M.E., Fiering, S., Galton, V.A., and St. Germain, D. 2006. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J. Clin. Invest. 116:476-484. doi:10.1172/JCI26240.
91. Huang, S.A., et al. 2005. TGF-B promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase. Mol. Endocrinol. 19:3126-3136.
92. Ng, L., et al. 2004. Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proc. Natl. Acad. Sci. U. S. A. 101:3474-3479.
93. Campos-Barros, A., et al. 2000. Type 2 iodothyronine deiodinase expression in the cochlea before the onset of hearing. Proc. Natl. Acad. Sci. U. S. A. 97:1287-1292.
94. Billon, N., Jolicoeur, C., Ying, Q.L., Smith, A., and Raff, M. 2002. Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J. Cell Sci. 115:3657-3665.
95. Barres, B.A., Lazar, M.A., and Raff, M.C. 1994. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development. 120:1097-1108.
96. Billon, N., Tokumoto, Y., Forrest, D., and Raff, M. 2001. Role of thyroid hormone receptors in timing oligodendrocyte differentiation. Dev. Biol. 235:110-120.
97. Guadano-Ferraz, A., Obregon, M.J., St. Germain, D.L., and Bernal, J. 1997. The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc. Natl. Acad. Sci. U. S. A. 94:10391-10396.
98. Wallace, V.A., and Raff, M.C. 1999. A role for Sonic hedgehog in axon-to-astrocyte signalling in the rodent optic nerve. Development. 126:2901-2909.
99. Stolow, M.A., and Shi, Y.B. 1995. Xenopus sonic hedgehog as a potential morphogen during embryogenesis and thyroid hormone-dependent metamorphosis. Nucleic Acids Res. 23:2555-2562.